Secondary amenorrhoea

Indication for Medroxyprogesterone

Population group: Suitable for women, only adults (18 - 65 years old)

For this indication, competent medicine agencies globally authorize below treatments:

2.5-10 mg once daily

Route of admnistration


Defined daily dose

2.5 - 10 mg

Dosage regimen

From 2.5 To 10 mg once every day

Detailed description

2.5 – 10 mg daily for 5 – 10 days beginning on the assumed or calculated 16th to 21st day of the cycle. Repeat the treatment for three consecutive cycles. In amenorrhoea associated with a poorly developed proliferative endometrium, conventional oestrogen therapy may be employed in conjunction with medroxyprogesterone acetate in doses of 5 – 10 mg for 10 days.

Active ingredient

Medroxyprogesterone acetate exerts anti-oestrogenic, anti-androgenic and antigonadotrophic effects.

Read more about Medroxyprogesterone

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner